gvtcx

Provision of GlpQ and Vlp15/16 Borrelia miyamotoi antigens

Public Health England Published 29 Jan 2019 Contracts Finder

key details

Value£15,000
Statuscomplete
Category (CPV) 24956000 +1 more
Deadline11 Feb 2019
Contract start14 Feb 2019
Contract end31 Mar 2020
Procedureopen
SME suitableYes
OCIDocds-b5fd17-ca134807-994d-4eea-bca4-a2a574b3a989

Award

SupplierValueDateStatus
The Native Antigen Company Limited £15,000 11 Feb 2019 active

description

Public Health England (PHE) awarded the contract for the Borrelia miyamotoi antigens (GlpQ and Vlp15/16) for its South West Regional Laboratory to The Native Antigen Company.

If you feel that you can meet the above requirements or would like more information, then please access the tender documents via link: https://phe.bravosolution.co.uk/

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
21 Jun 2019 Award (award) · b586f379-1686-489f-8469-65af931b5828-296878

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.